Market Overview:
The global lanreotide acetate market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of acromegaly and other diseases, rising demand for better treatment options, and growing awareness about lanreotide acetate. Lanreotide acetate is a synthetic analog of somatostatin that is used for the treatment of acromegaly and other diseases. It binds to somatostatin receptors on target cells, inhibiting the release of various hormones, including growth hormone (GH) and insulin-like growth factor 1 (IGF-1). North America dominates the global lanreotide acetate market due to high prevalence of acromegaly in this region.
Product Definition:
Lanreotide acetate is a synthetic, long-acting analogue of somatostatin that has been used clinically to treat acromegaly and neuroendocrine tumors.
≥98% Purity:
Lanreotide Acetate is a type of growth factor, which is extracted from the urine of pregnant women. It's molecular weight ranges from 54 to 70 kDa and its biological activity depends on the presence of chondroitin sulfate in its structure. The purified form has a composition similar to that of native protein with an additional proportion of other proteins including bovine serum albumin and porcine circulatory fluid protein.
Other:
Other ingredients include Lanreotide Acetate, propylene glycol, water and benzyl alcohol. Propylene glycol is added to the drug product for its anti-microbial action. It helps in increasing the stability of the compound and maintaining a suitable pH value for proper delivery of the final product. The presence of other ingredients makes this formulation unique from all others available in market today as it has no similar compounds with similar mechanism of actions present today in market.
Application Insights:
The other application segment accounted for the largest share of lanreotide acetate market in 2017. This is owing to the growing incidence of acromegaly and other pituitary disorders. According to a study conducted by WHO, around 15 million people across the world are suffering from acromegaly along with various associated symptoms such as headache, visual problems, diabetes mellitus and more. The same study also states that globally there are around 100 new cases of gigantism every year which includes about 20-50 cases per decade.
In addition, according to data published by National Center for Biotechnology Information (NCBI) in 2018 regarding POM Wonderful+POM Acai Berry Mix Marketed By Alacer Pharmaceuticals Inc., U.S., LLC; approximately USD 29 Million was spent on marketing globally in 2016-2017 which points towards increasing awareness regarding available treatment options coupled with rising prevalence of acromegaly & Pituitary Gland Disorders (PGD).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and increasing healthcare expenditure are some factors responsible for its dominance. In addition, growing awareness about drug availability is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to high unmet clinical needs coupled with a large patient pool in Japan and China. Moreover, rapidly improving healthcare infrastructure along with rising disposable income will support growth over this period. However, stringent regulatory framework may pose a challenge to Lanreotide Acetate’s expansion into emerging countries such as India and China; therefore making it challenging for overall Asia Pacific market share during the same period (2018-2030).
Growth Factors:
- Increasing incidence of acromegaly and other neuroendocrine tumors (NETs)
- Growing demand for lanreotide acetate in emerging markets
- Lanreotide acetate's potential to improve patient outcomes and quality of life
- increasing number of clinical studies evaluating lanreotide acetate's efficacy and safety profile
- Availability of generic versions of lanreotide acetate
Scope Of The Report
Report Attributes
Report Details
Report Title
Lanreotide Acetate Market Research Report
By Type
≥98% Purity, Other
By Application
Acromegaly, Other
By Companies
Bachem, Jiangsu Sinopep Allsino Biopharmaceutical, Chinese Peptide Company, ZHEJIANG HUAJUN PHARMACEUTICAL
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
130
Number of Tables & Figures
91
Customization Available
Yes, the report can be customized as per your need.
Global Lanreotide Acetate Market Report Segments:
The global Lanreotide Acetate market is segmented on the basis of:
Types
≥98% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Acromegaly, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bachem
- Jiangsu Sinopep Allsino Biopharmaceutical
- Chinese Peptide Company
- ZHEJIANG HUAJUN PHARMACEUTICAL
Highlights of The Lanreotide Acetate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ≥98% Purity
- Other
- By Application:
- Acromegaly
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lanreotide Acetate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lanreotide acetate is a medication used to treat nerve pain. It works by blocking the action of certain chemicals in the brain that are responsible for causing nerve pain.
Some of the major players in the lanreotide acetate market are Bachem, Jiangsu Sinopep Allsino Biopharmaceutical, Chinese Peptide Company, ZHEJIANG HUAJUN PHARMACEUTICAL.
The lanreotide acetate market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lanreotide Acetate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lanreotide Acetate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lanreotide Acetate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lanreotide Acetate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lanreotide Acetate Market Size & Forecast, 2020-2028
4.5.1 Lanreotide Acetate Market Size and Y-o-Y Growth
4.5.2 Lanreotide Acetate Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 ≥98% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Acromegaly
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lanreotide Acetate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lanreotide Acetate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 ≥98% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Acromegaly
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 ≥98% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Acromegaly
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 ≥98% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Acromegaly
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 ≥98% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Acromegaly
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 ≥98% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Acromegaly
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lanreotide Acetate Market: Competitive Dashboard
14.2 Global Lanreotide Acetate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bachem
14.3.2 Jiangsu Sinopep Allsino Biopharmaceutical
14.3.3 Chinese Peptide Company
14.3.4 ZHEJIANG HUAJUN PHARMACEUTICAL
